Find a Clinical Trial

Columbia University Department of Surgery is conducting hundreds of clinical trials to improve care for many types of conditions.

Use the tool below to find our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, links to the investigator’s biography, the trial’s eligibility criteria, and how to get more information.

Showing 1 - 10 of 213 trials

Specialty: Melanoma

A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 228 in Subjects with Selected Advanced Solid Tumors

Specialty: Melanoma

A Phase Ib/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects with Previously Untreated, Unresected, Stage IIIB-IV Melanoma

Specialty: Breast, Specialty: Oncology

A Multicenter “Ablate and Resect” Study of Novilase Interstitial Laser Therapy for the Ablation of Small Breast Cancers

Specialty: Breast, Specialty: Oncology

A Multicenter “Ablate and Resect” Study of Novilase Interstitial Laser Therapy for the Ablation of Small Breast Cancers

Specialty: Pancreas

A Phase II Study of Chemotherapy and Immune Checkpoint Blockade With Pembrolizumab in the Perioperative and Maintenance Treatment of Locoregional Gastric or GE Junction Adenocarcinoma

INVESTIGATOR: Gulam A. Manji, MD

Specialty: Thyroid, Specialty: Endocrine

A quantitative analysis of the effects of supersaturated potassium iodide (SSKI) on the vascularity of the thyroid gland in Graves’ Disease.

INVESTIGATOR: Jennifer Hong Kuo, MD

Specialty: Thyroid, Specialty: Endocrine

A quantitative analysis of the effects of supersaturated potassium iodide (SSKI) on the vascularity of the thyroid gland in Graves’ Disease.

INVESTIGATOR: Jennifer Hong Kuo, MD

Specialty: Kidney, Specialty: Transplant

A randomized, open-label, multicenter trial to determine safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in living donor kidney transplant recipients requiring desensitization therapy

INVESTIGATOR: Lloyd E. Ratner, MD

Specialty: Kidney, Specialty: Transplant

INVESTIGATOR: Lloyd E. Ratner, MD

Specialty: Pancreas

A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenoca

INVESTIGATOR: Susan E. Bates, MD

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Find a Clinical Trial

Choose Specialty Area: